Customs officers at Suvarnabhumi Airport arrested a Chinese passenger on May 23 after discovering 137 packages of Tirzepatide, a medication used for diabetes and weight loss, not cleared through customs. This seizure, valued at over 2.13 million baht (approximately $65,000), highlights enforcement efforts against unauthorized imports.
Get today's headlines by email 
The passenger arrived from Bangladesh and now faces charges under the Customs Act 2017 for importing goods without proper procedures. The individual is also charged under the Drug Act 1967, with potential additional charges related to the importation of controlled substances. Tirzepatide, primarily for type 2 diabetes treatment, is also gaining attention for its weight loss benefits, making it a high-demand item.
As Thailand recognizes World Diabetes Day, the Public Health Ministry has raised concerns about the 6.5 million Thais at risk for diabetes. Health Minister Somsak Thepsutin emphasized adopting healthier habits, noting that 40% of diabetics are unaware of their condition. The ministry promoted carbohydrate counting and balanced diets to reduce diabetes risk.
Programs by Thailand’s village health volunteer network also stress low-sugar diets and regular exercise. The Department of Disease Control (DDC) encourages reducing salty, oily, and sugary foods, while advising regular physical activity and stress management to maintain health.
Looking ahead, the arrested passenger will face legal proceedings, while Thai health authorities continue efforts to educate the public on diabetes prevention and management. This incident underscores the importance of regulatory compliance and the rising demand for diabetes-related treatments.
Join the discussion? 
Already a member? 
Adapted by ASEAN Now · The Thaiger · 26 May 2026
Recommended Comments
Create an account or sign in to comment